Literature DB >> 16536987

[Expression of costimulator 4-1BBL and B7-1 on glioma cell lines].

Yong-Gao Mu1, Hui Peng, Jun-Ying Zhang, Cui-Jie Shao, Chang-You Wu, Zhong-Ping Chen.   

Abstract

BACKGROUND &
OBJECTIVE: Costimulatory molecules 4-1BBL and B7-1 have been proposed to be therapeutic targets to improve and sustain antitumor immune response. This study was to investigate the expression of 4-1BBL and B7-1 on several glioma cell lines.
METHODS: The expression of 4-1BBL and B7-1 on glioma cell lines T98G, MGR2, MGR1, SF767, SKMG1, SKMG4, and UW28 was detected by flow cytometry. The cytotoxic effects of vincristine (VCR) on the glioma cell lines were assessed with MTT assay. The correlation of 4-1BBL expression to drug resistance was analyzed.
RESULTS: The 7 glioma cell lines showed various levels of 4-1BBL expression, but none expressed B7-1. The positive rate of 4-1BBL was above 30% in T98G and MGR1 cells which were resistant to VCR; while it was below 10% in MGR2, SF767, SKMG1, SKMG4, and UW28 cells which were sensitive to VCR.
CONCLUSIONS: All of the detected cell lines express 4-1BBL, but none expresses B7-1. The glioma cells with high 4-1BBL expression are resistant to VCR.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16536987

Source DB:  PubMed          Journal:  Ai Zheng


  3 in total

1.  Analysis of CD137L and IL-17 expression in tumor tissue as prognostic indicators for gliblastoma.

Authors:  Xiangli Cui; Zhiqin Xu; Zhigang Zhao; Dali Sui; Xiaohui Ren; Qiming Huang; Jiazhen Qin; Limin Hao; Zhenguang Wang; Li Shen; Song Lin
Journal:  Int J Biol Sci       Date:  2013-01-16       Impact factor: 6.580

2.  Construction of an immune-related gene signature for the prognosis and diagnosis of glioblastoma multiforme.

Authors:  Ziye Yu; Huan Yang; Kun Song; Pengfei Fu; Jingjing Shen; Ming Xu; Hongzhi Xu
Journal:  Front Oncol       Date:  2022-08-02       Impact factor: 5.738

3.  Induction of the unfolded protein response drives enhanced metabolism and chemoresistance in glioma cells.

Authors:  Laura M Epple; Rebecca D Dodd; Andrea L Merz; Anjelika M Dechkovskaia; Matthew Herring; Benjamin A Winston; Alex M Lencioni; Rae L Russell; Helen Madsen; Meheret Nega; Nathaniel L Dusto; Jason White; Darell D Bigner; Christopher V Nicchitta; Natalie J Serkova; Michael W Graner
Journal:  PLoS One       Date:  2013-08-15       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.